Clinical Trials for Recurrent Small Lymphocytic Lymphoma

Find clinical trials for recurrent small lymphocytic lymphoma. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

NCT ID: NCT07061951

This clinical trial is testing a new drug called mirdametinib to see if it can help people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back after treat...

Not yet recruiting

Phase: PHASE2 Type: interventional

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT ID: NCT04892277

This clinical trial is investigating a new type of treatment called CD19-directed CAR-T cell therapy for patients with specific types of blood cancers, particularly those whose cancer has come back...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

NCT ID: NCT06839053

This clinical trial is looking at a new treatment approach for patients with certain types of blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mant...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

NCT ID: NCT04941716

This clinical trial is studying a combination of two medications, acalabrutinib and venetoclax, to see how well they work together in treating patients with chronic lymphocytic leukemia (CLL) or sm...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Q702 for the Treatment of Patients With Hematologic Malignancies

NCT ID: NCT06712810

This clinical trial is studying a new medication called Q702 to see how safe it is and how well it works for people with certain types of blood cancers, known as hematologic malignancies. These can...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Rochester, Minnesota, United States

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT ID: NCT04169737

This clinical trial is studying a combination of three treatments—acalabrutinib, venetoclax, and possibly obinutuzumab—for patients with certain types of chronic lymphocytic leukemia (CLL) or small...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

NCT ID: NCT06191887

This clinical trial is investigating a new treatment approach for patients with certain types of blood cancers that have returned after treatment or have not responded well to previous therapies. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions